What’s Getting Health Officials In Trouble Under Xi's Graft Campaign?
This article was originally published in PharmAsia News
Taking luxury trips paid for by drug makers, dining with friends on official expenses, and drinking during working lunches are just some of the wrongdoings disclosed recently by China's Communist Party watchdog that have led to trouble for health officials. As a national anti-corruption campaign rolls into its third year, ever smaller and more trivial transgressions can land hospital heads in hot water.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.